Current pharmaceutical design · 2026
Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sankpal Pournima, Mane Shiom, Pathak Rashmi, Yasmeen Ayesha, Binshaya Abdulkarim S
Аннотация
INTRODUCTION: Cancer is a major global health problem characterized by uncontrolled cell proliferation, dysregulated cell cycle progression, and the ability of malignant cells to invade and metastasize to distant organs. Natural flavonoids such as rutin and hesperidin have demonstrated promising anticancer properties; however, their therapeutic application is limited due to poor aqueous solubility and low bioavailability.
METHOD: Therefore, the present study aimed to enhance the solubility and colon-targeting efficiency of rutin and hesperidin by formulating them into pectin-based nanoparticles. Pectin nanoparticles encapsulating rutin and hesperidin were prepared using the Probe Sonicator/High-Pressure Homogenizer (HPH) technique. The developed nanoparticles were characterized using X-ray Diffraction (XRD) and Differential Scanning Calorimetry (DSC). Transmission Electron Microscopy (TEM) analysis.
RESULTS AND DISCUSSION: Characterization studies confirmed nanoscale particle formation with suitable morphology and improved stability. Furthermore, the nanoformulation exhibited enhanced cytotoxic potential against colon cancer cells.
CONCLUSION: Pectin-based nanoparticles significantly improved the solubility and anticancer potential of rutin and hesperidin, indicating their promising role as a colon-targeted drug delivery system for colorectal cancer therapy.
METHOD: Therefore, the present study aimed to enhance the solubility and colon-targeting efficiency of rutin and hesperidin by formulating them into pectin-based nanoparticles. Pectin nanoparticles encapsulating rutin and hesperidin were prepared using the Probe Sonicator/High-Pressure Homogenizer (HPH) technique. The developed nanoparticles were characterized using X-ray Diffraction (XRD) and Differential Scanning Calorimetry (DSC). Transmission Electron Microscopy (TEM) analysis.
RESULTS AND DISCUSSION: Characterization studies confirmed nanoscale particle formation with suitable morphology and improved stability. Furthermore, the nanoformulation exhibited enhanced cytotoxic potential against colon cancer cells.
CONCLUSION: Pectin-based nanoparticles significantly improved the solubility and anticancer potential of rutin and hesperidin, indicating their promising role as a colon-targeted drug delivery system for colorectal cancer therapy.